[F-18]RGD-K5 | Interleukin Related interleukin-related.com

Product Name :
[F-18]RGD-K5

Search keywords :
RGD

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Positron-emission tomography enhancers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Siemens

Active Company_Name :
Siemens

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cleaved-PARP1 Antibody
STAT1 Antibody (YA667)
eIF5A Antibody: eIF5A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to eIF5A. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts